KRTCAP2 as an immunological and prognostic biomarker of hepatocellular carcinoma.

[1]  A. Lujambio,et al.  The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma , 2022, Hepatology.

[2]  A. Zhu,et al.  Interferon-a potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment. , 2022, Cancer discovery.

[3]  T. Kang,et al.  Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response , 2022, Cell Research.

[4]  Qian Ning,et al.  Tumor microenvironment based stimuli-responsive CRISPR/Cas delivery systems: A viable platform for interventional approaches. , 2021, Colloids and surfaces. B, Biointerfaces.

[5]  L. Qin,et al.  GOLM1 exacerbates CD8+ T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages , 2021, Signal Transduction and Targeted Therapy.

[6]  N. Ren,et al.  The spatial distribution of immune cell subpopulations in hepatocellular carcinoma , 2021, Cancer Science.

[7]  S. Freeman,et al.  The glycocalyx and immune evasion in cancer , 2021, The FEBS journal.

[8]  Yifan Yang,et al.  Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma , 2021, Frontiers in Oncology.

[9]  M. Ebert,et al.  Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. , 2021, Journal of hepatology.

[10]  Shanshan Wang,et al.  Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma , 2021, Frontiers in Immunology.

[11]  Jason S. Mitchell,et al.  Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses , 2021, Scientific Reports.

[12]  Jianfei Huang,et al.  GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer , 2021, Frontiers in Immunology.

[13]  Shixiang Wang,et al.  UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena data , 2021, Bioinform..

[14]  Xuesi Chen,et al.  Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy , 2021, Bioactive materials.

[15]  L. Qin,et al.  Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC , 2021, Hepatology.

[16]  B. Sangro,et al.  Advances in immunotherapy for hepatocellular carcinoma , 2021, Nature Reviews Gastroenterology & Hepatology.

[17]  E. Ruppin,et al.  Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma , 2021, Nature communications.

[18]  G. Cabibbo,et al.  Antiviral therapy in the palliative setting of HCC (BCLC B and C). , 2021, Journal of hepatology.

[19]  J. Chiu,et al.  Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors , 2021, Journal for ImmunoTherapy of Cancer.

[20]  Huanming Yang,et al.  Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma , 2020, Cell.

[21]  Liangrong Shi,et al.  High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells , 2020, Gut.

[22]  M. Yuen,et al.  Lysyl Oxidase‐Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis , 2020, Hepatology.

[23]  A. Balakrishnan,et al.  MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. , 2020, Journal of hepatology.

[24]  W. Dai,et al.  Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma , 2020, Journal of Experimental & Clinical Cancer Research.

[25]  Dong Wang,et al.  An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma , 2020, Cancer Immunology, Immunotherapy.

[26]  X. Wang,et al.  Intratumoral γδ T‐Cell Infiltrates, Chemokine (C‐C Motif) Ligand 4/Chemokine (C‐C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma , 2020, Hepatology.

[27]  Wei-wei Wang,et al.  Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma , 2020, Aging.

[28]  Erwin G. Van Meir,et al.  A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis , 2020, Clinical Cancer Research.

[29]  Z. Dai,et al.  Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors , 2019, Oncoimmunology.

[30]  Shanshan Liu,et al.  From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma , 2019, Journal of Experimental & Clinical Cancer Research.

[31]  A. Attarbaschi,et al.  PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whole spectrum of PTLD categories , 2019, Cancer medicine.

[32]  J. Serody,et al.  Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. , 2018, Blood.

[33]  Y. Abe,et al.  Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification , 2018, Hepatology.

[34]  B. Ueberheide,et al.  A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. , 2017, Cancer cell.

[35]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[36]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[37]  K. Kaestner,et al.  Genetic lineage tracing analysis of the cell of origin of hepatotoxin‐induced liver tumors in mice , 2016, Hepatology.

[38]  N. Packer,et al.  Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity , 2015, Journal of Virology.

[39]  Vipin Kumar,et al.  Revival of CD8+ Treg-mediated suppression. , 2008, Trends in immunology.

[40]  J. Zucman‐Rossi,et al.  Hepatocellular carcinoma , 1998, Nature Reviews Disease Primers.